Economic Atlas
Companies/Clene Inc.
Company profile

Clene Inc.

NASDAQ: CLNN · Healthcare · Biotechnology
PublicHQ Salt Lake City, UT · Salt LakeCIK 0001822791Reports USD
#1001 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
27D
Revenue TTM
$134.0k
Rev growth YoY (TTM)
-61.7%
Net income (FY)
-$26.2M
Employees
78
as of 2026-08-19
Market cap
$52.3M
as of 2026-08-19

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$200.0k$200.0k2025
Net income-$26.2M-$26.2M2025
Operating income-$23.1M-$23.1M2025
Total assets$18.1M$18.1M2025
Liabilities$35.7M$35.7M2025
Equity-$17.6M-$17.6M2025

Revenue trend

FY2020 – FY2025 · USD
FY20
FY22
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product60%
Royalty41%
By geography

Not disclosed.

The read

What is Clene Inc.’s revenue?

Clene Inc. booked $200.0k in FY2025 revenue, contracting 42% year over year — slower than 79% of Healthcare companies we track, at a -13086.5% net margin.

Peers · Healthcare
GlucoTrack, Inc.28DSharps Technology, Inc.33DLixte Biotechnology Holdings, Inc.40DWindtree Therapeutics, Inc.——CardioComm Solutions, Inc.25DBioxytran, Inc.27D
Neighbors
Salt Lake →
Extra Space Storage Inc.$129.5M67BZions Bancorporation, National Association$529.0M57CHealthEquity, Inc.$1.3B82B+Merit Medical Systems, Inc.$1.5B83B+Rest Ez Inc.$0——PROG Holdings, Inc.$2.4B72B
Key facts
CEORobert Etherington
SectorHealthcare
IndustryBiotechnology
HeadquartersSalt Lake City, UT
ExchangeNASDAQ: CLNN
Employees78
IPO date2018-10-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.